Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38713

ANXA11 Knockout A549 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Lung adenocarcinoma

The ANK3 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited population of human lung adenocarcinoma epithelial cells with targeted disruption of the ANK3 gene, which encodes ankyrin-G. Ankyrin-G scaffolds membrane proteins like E-cadherin and voltage-gated sodium channels to the spectrin-actin cytoskeleton, making its loss-of-function valuable for studying adhesion, polarity, and ion channel localization in an alveolar type II model. Regulated by Wnt/??-catenin and SP1/REST, ankyrin-G interacts with ??-spectrin and ??-catenin to organize membrane domains. This polyclonal knockout pool is ideal for western blotting, immunofluorescence, migration assays, and drug profiling, enabling population-level analysis without clonal bias.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    A549

    Sex of Donor

    Male

    Age

    58 years

    Derived From Site

    Lung

    Gene Name

    ANXA11

    Gene Identifier

    NCBI Gene ID 311

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ANK3 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of A-549 cells featuring targeted disruption of the ANK3 gene, which encodes the scaffolding protein ankyrin-G. This polyclonal knockout pool retains genetic heterogeneity, making it suitable for population-based assays that avoid clonal artifacts. The model enables investigation of ankyrin-G loss-of-function in a human lung epithelial carcinoma background, facilitating studies of membrane-cytoskeletal interactions, adhesion, and polarity.

The A-549 host cell line is a human lung adenocarcinoma-derived epithelial line widely used as a model of alveolar type II pneumocytes. These cells grow as adherent monolayers and exhibit characteristic epithelial features, including expression of surfactant proteins. Their stable karyotype and reproducible behavior make them a standard platform for respiratory disease research, cancer biology, and drug screening. For cytoskeletal and adhesion studies, A-549 cells provide a relevant epithelial context to assess the consequences of ANK3 disruption on cellular architecture.

Ankyrin-G functions as a master scaffold that tethers transmembrane proteins??such as E-cadherin, voltage-gated sodium channels, neurofascin, and L1CAM??to the spectrin-actin cytoskeleton. It organizes membrane domains essential for cell adhesion, ion channel clustering, and epithelial polarity. ANK3 expression is controlled by transcription factors SP1 and REST, and ankyrin-G stability at cell junctions is enhanced by Wnt/??-catenin signaling. Downstream, ankyrin-G interacts with ??-spectrin and adducin to reinforce the cortical actin network, stabilizes the cadherin-catenin complex, and participates in clathrin-mediated endocytosis. Knockout disrupts these interactions, leading to adhesion defects and mislocalization of partner proteins.

In A-549 cells, ANK3 knockout profoundly impacts adherens junctions and the cortical cytoskeleton, resulting in weakened cell-cell adhesion, altered epithelial polarity, and increased migratory behavior. This phenotype is directly relevant to epithelial-mesenchymal transition, cancer invasion, and metastasis research. Although ANK3 mutations are linked to neuropsychiatric and cardiac disorders, the fundamental role of ankyrin-G in membrane organization is conserved, making this knockout model valuable for dissecting ankyrin-G biology in a non-neuronal, cancer-relevant system.

This polyclonal knockout model supports diverse applications. Western blotting and immunofluorescence confirm ankyrin-G loss and assess partner proteins like E-cadherin. Co-immunoprecipitation reveals altered protein complexes, while cell adhesion and transwell migration assays quantify functional defects. Immunostaining for ion channels elucidates clustering disruptions. The polyclonal nature ensures robust population-level phenotypes, ideal for drug response profiling and screening. For further information, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)